Monday Dec 23, 2024
Maruti Cements Ad
Monday Dec 23, 2024

Ulceration

Melanoma patients benefit from immunotherapy drug: Study

Sep 20, 2021
According to the results of an international, randomised phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Maruti Cements

Recent News

Nepalnews
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,


Newsroom
##

E-mail
nepalnewseditor@gmail.com

Social Media

Exploration

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal